During the past decade, Opolskie Centrum Onkologii w Opolu im. prof. Tadeusza Koszarowskiego conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Opolskie Centrum Onkologii w Opolu im. prof. Tadeusza Koszarowskiego" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Institut de Recherches Internationales Servier" with 2 trials sponsored, "Taiho Oncology, Inc." with 2 trials sponsored and "Alliance Foundation Trials, LLC." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Opolskie Centrum Onkologii w Opolu im. prof. Tadeusza Koszarowskiego" #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Opolskie Centrum Onkologii w Opolu im. prof. Tadeusza Koszarowskiego" are "Breast Cancer" (3 trials), "Metastatic Colorectal Cancer" (2 trials), "Neoplasm Metastasis" (2 trials), "Abiraterone Acetate" (1 trials) and "Androgens" (1 trials). Many other conditions were trialed in "Opolskie Centrum Onkologii w Opolu im. prof. Tadeusza Koszarowskiego" in a lesser frequency.

Most popular intervention types in "Opolskie Centrum Onkologii w Opolu im. prof. Tadeusza Koszarowskiego" are "Drug" (17 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Abemaciclib" (3 trials), "5-Fluorouracil" (2 trials), "Abiraterone" (2 trials) and "Atezolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Opolskie Centrum Onkologii w Opolu im. prof. Tadeusza Koszarowskiego" are 15 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Opolskie Centrum Onkologii w Opolu im. prof. Tadeusza Koszarowskiego". undefined are not yet recruiting, 3 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Opolskie Centrum Onkologii w Opolu im. prof. Tadeusza Koszarowskiego, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Opolskie Centrum Onkologii w Opolu im. prof. Tadeusza Koszarowskiego, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".